Furthermore, the same authors [39] showed that the methylation levels of four of the six genes described (RASSF1A, CDH1, p16, and RUNX3) were significantly different in both tissue and serum samples in patients with HCC. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.